Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine

Pharmacopsychiatry

Volumn 35, Issue 6, 2002, Pages 220-225

  Kraus, T ^a   Haack, M ^a   Schuld, A ^a   Hinze Selch, D ^b   Koethe, D ^a   Pollmächer, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Antidepressants; Immune system; Leptin; TNF ; Weight

Indexed keywords

CYTOKINE; LEPTIN; MIRTAZAPINE; PROTEIN P75; PSYCHOTROPIC AGENT; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VENLAFAXINE;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOCRINE SYSTEM; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; SOLUBILITY; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; BODY WEIGHT; CROSS-OVER STUDIES; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LEPTIN; LONGITUDINAL STUDIES; MALE; MIANSERIN; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036869374     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36390     Document Type: Article

References (51)

1. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686-1696
2. th Edition. In: APA Press, Washington, D.C.: 1994
3. Argiles JM, Lopez-Soriano J, Busquets S, Lopez-Soriano FJ. Journey from cachexia to obesity by TNF. FASEB J 1997; 11: 743-751
4. Baptista T. Body weight gain induced by antipsychotic drugs: Mechanisms and management. Acta Psychiatr Scand 1999; 100: 3-16
5. Baptista T, Lacruz A, Angeles F, Silvera R, de Mendoza S, Mendoza MT, Hernandez L. Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration. Pharmacopsychiatry 2001; 34: 23-231
6. Baptista T, Lacruz A, de Mendoza S, Mendoza Guillen JM, Silvera R, Angeles F, Mendoza MT, Hernandez L. Body weight gain after administration of antipsychotic drugs: Correlation with leptin, insulin and reproductive hormones. Pharmacopsychiatry 2000; 33: 81-88
7. Bergmann M, Gornikiewicz A, Sautner T, Waldmann E, Weber T, Mittlbock M et al. Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock 1999; 12: 421-427
8. Brömel T, Blum WF, Ziegler A, Schulz E, Bender M, Fleischhaker C et al. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry 1998; 3: 76-80
9. Burrows GD, Kremer CM. Mirtazapine: Clinical advantages in the treatment of depression. J Clin Psychopharmacol 1997; 17 Suppl: 34-39
10. Cook EB, Stahl JL, Barney NP, Graziano FM. Olopatadine inhibits TNF-α release from human conjunctival mast cells. Ann Allergy Asthma Immunol 2000; 84: 504-508
11. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: Fall with weight loss. J Clin Endocrinol Metab 1998; 83: 2907-2910
12. da-Silva VA, Altenburg SP, Malheiros LR, Thomaz TG, Lindsey CJ. Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy. Braz J Med Biol Res 1999; 32: 93-98
13. Davis R, Wilde MI. Mirtazapine. A review of its pharmacology and therapeutic potential in the management of major depression. CNS Drugs 1996; 5: 389-402
14. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879-884
15. Fava M. Weight gain and antidepressants. J Clin Psychiatry 2000; 61 Suppl 11: 37-41
16. Fernstrom MH, Kupfer DJ. Antidepressant-induced weight gain: A comparison study of four medications. Psychiatry Res 1988; 26: 265-271
17. Garland EJ, Remick RA, Zis AP. Weight gain with antidepressants and lithium. J Clin Psychopharmacol 1988; 8: 323-330
18. Geha RS, Meltzer EO. Desloratadine: A new, nonsedating, oral antihistamine. J Allergy Clin Immunol 2001; 107: 751-762
19. Guelfi JD, White C, Hackett D, Guichoux JY, Magni G. Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. J Clin Psychiatry 1995; 56: 450-458
20. Hauner H, Bender M, Haastert B, Hube F. Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord 1998; 22: 1239-1243
21. Hinze-Selch D, Deuschle M, Weber B, Heuser I, Pollmächer T. Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight. Psychopharmacology (Berl) 2000; 149: 163-169
22. Hinze-Selch D, Schuld A, Kraus T, Kühn M, Uhr M, Haack M et al. Effects of antidepressants on weight and on the plasma levels of leptin, TNF- and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacol 2000; 23: 13-19
23. Hotamisligil GS. The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621-625
24. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91
25. Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br J Pharmacol 1997; 121: 1758-1762
26. Kraus T, Haack M, Schuld A, Hinze-Selch D, Kühn M, Uhr M et al. Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 1999; 156: 312-314
27. Kraus T, Zimmermann U, Schuld A, Haack M, Hinze-Selch D, Pollmächer T. The physiopathology of weight regulation during treatment with psychotropic drugs. Fortschr Neurol Psychiatr 2001; 69: 116-137
28. Lofgren P, van H V, Reynisdottir S, Naslund E, Ryden M, Rossner S et al. Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes 2000; 49: 688-692
29. Meltzer HY, Nash JF. Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 1991; 43: 587-604
30. Mercer LP. Histamine and the neuroregulation of food intake. Nutrition 1997; 13: 581-582
31. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res Clin Pract 2001; 52: 119-123
32. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-908
33. Morimoto T, Yamamoto Y, Mobarakeh JI, Yanai K, Watanabe T, Yamatodani A. Involvement of the histaminergic system in leptin-induced suppression of food intake. Physiol Behav 1999; 67: 679-683
34. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543
35. Pollmächer T, Haack M, Schuld A, Kraus T, Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res 2000; 34: 369-382
36. Pollmächer T, Hinze-Selch D, Fenzel T, Kraus T, Schuld A, Mullington J. Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am J Psychiatry 1997; 154: 1763-1765
37. Pollmächer T, Hinze-Selch D, Mullington J. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol 1996; 16: 403-409
38. Pollmächer T, Kraus T, Haack M, Uhr M, Mullington J. Salmonella abortus equi endotoxin does not affect leptin plasma levels in healthy humans. J Infect Dis 1999; 179: 1047-1048
39. Roose SP. Tolerability and patient compliance. J Clin Psychiatry 1999; 60 Suppl 17: 14-17
40. Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ et al. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med 1997; 185: 171-175
41. Sewter CP, Digby JE, Blows F, Prins J, O'Rahilly S. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol 1999; 163: 33-38
42. Schuld A, Kraus T, Haack M, Hinze-Selch D, Kühn M, Pollmächer T. Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophr Res 2000; 102: 1-3
43. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte DJ. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nat Med 1996; 2: 589-593
44. Schwartz MW, Woods SC, Porte DJ, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671
45. Stanton JM. Weight gain associated with neuroleptic medication: A review. Schizophr Bull 1995; 21: 463-472
46. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995; 374: 542-546
47. Tracey KJ, Cerami A. Tumor necrosis factor: An updated review of its biology. Crit Care Med 1993; 21 Suppl: 415-422
48. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614
49. Wang KY, Arima N, Higuchi S, Shimajiri S, Tanimoto A, Murata Y et al. Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages. FEBS Lett 2000; 473: 345-348
50. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341: 427-434
51. Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R et al. Illness, cytokines, and depression. Ann N Y Acad Sci 2000; 917: 478-487